Search
Go
Share this page:
Pathways : WP733: Serotonin Receptor 2 and STAT3 SignalingWP927: Signaling of Hepatocyte Growth Factor ReceptorWP1913: Signaling by Insulin receptorWP780: T Cell Receptor Signaling PathwayWP88: Toll Like Receptor signalingWP1011: T Cell Receptor Signaling PathwayWP1121: Kit Receptor Signaling PathwayWP1235: Signaling of Hepatocyte Growth Factor ReceptorWP1162: Signaling of Hepatocyte Growth Factor ReceptorWP407: Kit Receptor Signaling PathwayWP75: Toll-like receptor signaling pathwayWP794: B Cell Receptor Signaling PathwayWP897: Androgen receptor signaling pathwayWP1130: T Cell Receptor Signaling PathwayWP193: Signaling of Hepatocyte Growth Factor ReceptorWP2292: Chemokine signaling pathwayWP1025: B Cell Receptor Signaling PathwayWP1271: Toll-like receptor signaling pathwayWP1367: TGF-beta Receptor Signaling PathwayWP1336: EPO Receptor SignalingWP768: EPO Receptor SignalingWP1183: Toll-like receptor signaling pathwayWP313: Signaling of Hepatocyte Growth Factor ReceptorWP809: TGF-beta Receptor Signaling PathwayWP1144: B Cell Receptor Signaling Pathway Related Genes : [EPOR] Erythropoietin receptor (EPO-R) [Epor] Erythropoietin receptor (EPO-R) [Epor] Erythropoietin receptor (EPO-R) [SOCS3 CIS3 SSI3] Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (STAT-induced STAT inhibitor 3) (SSI-3) [Socs3 Cis3 Cish3] Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) (CIS-3) (Protein EF-10) [Socs3 Cish3] Suppressor of cytokine signaling 3 (SOCS-3) (Cytokine-inducible SH2 protein 3) [CISH G18] Cytokine-inducible SH2-containing protein (CIS) (CIS-1) (Protein G18) (Suppressor of cytokine signaling) (SOCS) [CD244 2B4] Natural killer cell receptor 2B4 (NK cell activation-inducing ligand) (NAIL) (NK cell type I receptor protein 2B4) (NKR2B4) (h2B4) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244) [Cd244 2b4 Nmrk] Natural killer cell receptor 2B4 (NK cell type I receptor protein 2B4) (NKR2B4) (Non-MHC restricted killing associated) (SLAM family member 4) (SLAMF4) (Signaling lymphocytic activation molecule 4) (CD antigen CD244) [SOCS2 CIS2 SSI2 STATI2] Suppressor of cytokine signaling 2 (SOCS-2) (Cytokine-inducible SH2 protein 2) (CIS-2) (STAT-induced STAT inhibitor 2) (SSI-2) [FRS2] Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (Suc1-associated neurotrophic factor target 1) (SNT-1) [Frs2 Frs2a] Fibroblast growth factor receptor substrate 2 (FGFR substrate 2) (FGFR-signaling adaptor SNT) (FRS2-alpha) (Suc1-associated neurotrophic factor target 1) (SNT-1) [MINAR1 KIAA1024 UBTOR] Major intrinsically disordered Notch2-binding receptor 1 (Membrane integral NOTCH2-associated receptor 1) (Ubiquitination and mTOR signaling protein) [SLA2 C20orf156 SLAP2] Src-like-adapter 2 (Modulator of antigen receptor signaling) (MARS) (Src-like adapter protein 2) (SLAP-2) [FRS3] Fibroblast growth factor receptor substrate 3 (FGFR substrate 3) (FGFR-signaling adaptor SNT2) (Suc1-associated neurotrophic factor target 2) (SNT-2) [Nsmf Jac Nelf] NMDA receptor synaptonuclear signaling and neuronal migration factor (Juxtasynaptic attractor of caldendrin on dendritic boutons protein) (Jacob protein) (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor) [ARHGAP32 GRIT KIAA0712 RICS] Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (GTPase regulator interacting with TrkA) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP) [Nsmf Jac Nelf] NMDA receptor synaptonuclear signaling and neuronal migration factor (Juxtasynaptic attractor of caldendrin on dendritic boutons protein) (Jacob protein) (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor) [UBASH3B KIAA1959 STS1] Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2) [Ubash3b Sts1] Ubiquitin-associated and SH3 domain-containing protein B (EC 3.1.3.48) (Cbl-interacting protein p70) (Suppressor of T-cell receptor signaling 1) (STS-1) (T-cell ubiquitin ligand 2) (TULA-2) (Tyrosine-protein phosphatase STS1/TULA2) [NSMF NELF] NMDA receptor synaptonuclear signaling and neuronal migration factor (Nasal embryonic luteinizing hormone-releasing hormone factor) (Nasal embryonic LHRH factor) [Arhgap32 Grit Kiaa0712 Rics] Rho GTPase-activating protein 32 (Brain-specific Rho GTPase-activating protein) (GAB-associated Cdc42/Rac GTPase-activating protein) (GC-GAP) (Rho-type GTPase-activating protein 32) (Rho/Cdc42/Rac GTPase-activating protein RICS) (RhoGAP involved in the beta-catenin-N-cadherin and NMDA receptor signaling) (p200RhoGAP) (p250GAP) [EPO] Erythropoietin (Epoetin) [UBASH3A STS2] Ubiquitin-associated and SH3 domain-containing protein A (Cbl-interacting protein 4) (CLIP4) (Suppressor of T-cell receptor signaling 2) (STS-2) (T-cell ubiquitin ligand 1) (TULA-1) [EPOR] Erythropoietin receptor (EPO-R) [BSK3 RLCK173 Os04g0684200 LOC_Os04g58750 OsJ_16683 OSJNBa0088H09.6] Probable serine/threonine-protein kinase BSK3 (EC 2.7.11.1) (Brassinosteroid-signaling kinase 3) (OsBSK3) (Receptor-like cytoplasmic kinase 173) (OsRLCK173) [CD320 8D6A UNQ198/PRO224] CD320 antigen (8D6 antigen) (FDC-signaling molecule 8D6) (FDC-SM-8D6) (Transcobalamin receptor) (TCblR) (CD antigen CD320) [Lepr Db Obr] Leptin receptor (LEP-R) (B219) (OB receptor) (OB-R) (CD antigen CD295) [BSK12 SSP At2g17090 F6P23.23] Probable inactive receptor-like kinase BSK12 (Brassinosteroid-signaling kinase 12) (Protein SHORT SUSPENSOR) [Epo] Erythropoietin Bibliography : [31800957] Erythroferrone lowers hepcidin by sequestering BMP2/6 heterodimer from binding to the BMP type I receptor ALK3.[31697835] Specific stimulation of T lymphocytes with erythropoietin for adoptive immunotherapy.[31689455] Erythropoietin attenuates vascular calcification by inhibiting endoplasmic reticulum stress in rats with chronic kidney disease.[31679265] The Molecular Mechanism of EPO Regulates the Angiogenesis after Cerebral Ischemia through AMPK-KLF2 Signaling Pathway.[31658577] Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.[31533545] Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.[31379495] Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity.[31357108] The combined effects of salinity, hypoxia, and oil exposure on survival and gene expression in developing sheepshead minnows, Cyprinodon variegatus.[31322257] Erythropoietin receptor induces a paclitaxel resistance phenotype in mammary adenocarcinoma cells.[31279934] Transmembrane Protein Aptamer Induces Cooperative Signaling by the EPO Receptor and the Cytokine Receptor β-Common Subunit.